FDA Clearance Tracker · P990078-S004
SUNRISE TECHNOLOGIES HYPERION(TM) HOLMIUM LASER SYSTEM FOR LASER THERMAL KERATOPLASTY (LTK)
Last checked: Nov 20, 2026Latest source record: Mar 16, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Mar 16, 2001
Approved
Time to decision
80 days
Received Dec 26, 2000. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P990078-S004
- Device name
- SUNRISE TECHNOLOGIES HYPERION(TM) HOLMIUM LASER SYSTEM FOR LASER THERMAL KERATOPLASTY (LTK)
- Applicant
- Sunrise Technologies, Inc.
- Applicant location
- Fremont, CA
- Received
- Dec 26, 2000
- Decided
- Mar 16, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P990078
Device type
- Device type
- Laser, ophthalmic (HQF)
- Device class
- Class II
- Regulation
- 21 CFR 886.4390
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A SOFTWARE MODIFICATION TO THE EYE TRACKER.
Source documents
Other decisions for Sunrise Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.